Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Europe Diabetes Care Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Europe Diabetes Care Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Europe Diabetes Care Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Europe Diabetes Care Devices Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Blood Glucose Monitoring Devices
4.3.1. Blood Glucose Monitoring Devices Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Self-Monitoring Devices
4.3.2.1. Self-Monitoring Devices Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.2. Blood Glucose Meter
4.3.2.2.1. Blood Glucose Monitoring Devices Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.3. Testing Strips
4.3.2.3.1. Testing Strips Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.4. Lancets
4.3.2.4.1. Lancets Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Continuous Glucose Monitoring Devices
4.3.3.1. Continuous Glucose Monitoring Devices Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.2. Sensors
4.3.3.2.1. Sensors Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.3. Transmitter
4.3.3.3.1. Transmitter Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.4. Receiver
4.3.3.4.1. Receiver Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Insulin Delivery Devices
4.4.1. Insulin Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Pens
4.4.2.1. Pens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Pumps
4.4.3.1. Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Syringes
4.4.4.1. Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Jet Injector
4.4.5.1. Jet Injector Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Europe Diabetes Care Devices Market: Distribution Channel Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Europe Diabetes Care Devices Market: Distribution Channel Movement Analysis, USD Million, 2023 & 2030
5.3. Hospital Pharmacies
5.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Retail Pharmacies
5.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Diabetes Clinics/Centers
5.5.1. Diabetes Clinics/Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Online Pharmacies
5.6.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Distribution Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Europe Diabetes Care Devices Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Europe Diabetes Care Devices Market: End Use Movement Analysis, USD Million, 2023 & 2030
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diagnostic Centers
6.4.1. Diagnostics Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Homecare
6.5.1. Homecare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Europe Diabetes Care Devices Market: Country Estimates & Trend Analysis
7.1. Europe Diabetes Care Devices Market Share, By Countries, 2023 & 2030, USD Million
7.2. UK
7.2.1. UK Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Germany
7.3.1. Germany Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. France
7.4.1. France Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Italy
7.5.1. Italy Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Spain
7.6.1. Spain Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Denmark
7.7.1. Denmark Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Sweden
7.8.1. Sweden Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Norway
7.9.1. Norway Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Medtronic plc
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/Strategic Initiatives
8.4.2. Abbott Laboratories
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/Strategic Initiatives
8.4.3. F. Hoffmann-La Roche Ltd.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/Strategic Initiatives
8.4.4. Bayer AG
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/Strategic Initiatives
8.4.5. LifeScan IP Holdings, LLC
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/Strategic Initiatives
8.4.6. B. Braun Melsungen AG
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/Strategic Initiatives
8.4.7. Dexcom, Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/Strategic Initiatives
8.4.8. Insulet Corporation
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/Strategic Initiatives
8.4.9. Companion Medical, Inc.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/Strategic Initiatives
8.4.10. Sanofi S.A.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/Strategic Initiatives
8.4.11. Valeritas Holdings, Inc.
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/Strategic Initiatives
8.4.12. Novo Nordisk A/S
8.4.12.1. Participant’s Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Recent Developments/Strategic Initiatives
8.4.13. Arkray, Inc.
8.4.13.1. Participant’s Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Recent Developments/Strategic Initiatives